# Maternal Antiviral Treatment and Infants Immunoprophylaxis in the Prevention of Mother-to-child Transmission

> **NCT03977987** · — · COMPLETED · sponsor: **Huashan Hospital** · enrollment: 233 (actual)

## Conditions studied

- Hepatitis B

## Interventions

- **DRUG:** nucleos(t)ide analogue

## Key facts

- **NCT ID:** NCT03977987
- **Lead sponsor:** Huashan Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01-01
- **Primary completion:** 2018-12-30
- **Final completion:** 2018-12-30
- **Target enrollment:** 233 (ACTUAL)
- **Last updated:** 2019-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03977987

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03977987, "Maternal Antiviral Treatment and Infants Immunoprophylaxis in the Prevention of Mother-to-child Transmission". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03977987. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*